UK medtech startup CoMind raises $102.5M led by Plural to advance AI-powered brain monitoring

On By admin

UK medtech startup CoMind raises $102.5M led by Plural to advance AI-powered brain monitoring

CoMind, a UK startup building optical sensing technology to revolutionize brain monitoring and treatment, has secured $102.5 million in Series A funding to help us redefine how we monitor and treat the brain. The round was led by Plural, with participation from existing investors.

About CoMind

  • CoMind is a London-based medical technology company, founded by James Dacombe, which developing a non-invasive brain monitoring system that uses light to provide a detailed view of brain activity. 

  • Its platform can non-invasively measure three core brain health indicators – cerebral blood flow, autoregulation and intracranial pressure

  • Its AI-powered platform, CoVision, delivers predictive insights to help clinicians detect and prevent complications. The technology aims to improve patient outcomes in settings such as intensive care, surgery, and emergency medicine.

“The company is led by a true outlier of a young founder, James Dacombe. He started programming when he was 13 and founded CoMind when he was just 17. His work ethic and rapid learning rate have led him to build a working product and take it through two successful clinical research studies, with the help of a stellar leadership team of medical and industry veterans from the likes of Medtronic, Tufts Medical Center and UCL,” says Taavet Hinrikus, Partner at Plural.

Investment details 

  • The round was led by Plural, with a $60 million investment. Plural is a Tallinn and London-based venture capital firm established by former startup founders to provide hands-on support to early-stage companies. It focuses on sectors such as artificial intelligence, frontier tech, and climate & energy.

  • Existing investors such as Angelini Ventures, LocalGlobe, Octopus Ventures, Crane Venture Partners, BACKED VC and Entrepreneurs First also participated in the round.

CoMind will use the funding to obtain regulatory approval, expand its brain monitoring technology to new medical applications, and develop an AI system for real-time analysis and personalized treatment guidance.

Read more: UK cybersecurity startup Theodosian raises $1.3M to scale enterprise data protection, joined by Estonian Startup Wise Guys

Powered by WPeMatico

https://en.ain.ua/2025/10/20/comind-raises-1025m/